Facilitating Trade in Pharmaceuticals: A Response to the COVID-19 Pandemic
This paper reviews trade in pharmaceutical products, focusing on ASEAN countries. Trade in this sector is of singular policy importance as a result of the COVID-19 pandemic. First, the paper shows that pharmaceuticals are traded within Global Value Chains, which in turn means that international linkages are complex. Second, the paper shows that policy reforms can help boost trade in the sector, which has important human development implications during the pandemic period.
This research was conducted as a part of the project ‘ERIA Research on Covid-19’ at the Economic Research Institute for ASEAN and East Asia (ERIA).
Facilitating Trade in Pharmaceuticals: A Response to the COVID-19 Pandemic
Related Articles

COVID-19 and Socio-Economic Inequalities in Indonesia: A Subnational-level Analysis
22 April 2021
This study examines if COVID-19 has worsened socio-economic inequalities across provinces in Indonesia, and if it has affected the spatial disparity in provincial-level socio-economic indicators. …

The Effect of the COVID-19 Pandemic on Global Production Sharing in East Asia
21 April 2021
This paper examines the effect of the COVID-19 pandemic on global production sharing in ASEAN Member States. Product-level analysis – on hard disk drives, air …